Stantec (STN) Tops Q2 EPS by 31c, provides guidance

Stantec (NYSE: STN) reported Q2 EPS of Cdn$1.12, Cdn$0.31 better than the analyst estimate of Cdn$0.81. Revenue for the quarter came in at Cdn$1.5 billion versus the consensus estimate of Cdn$1.08 billion.

Guidance:
Net revenue growth: 12% to 15%
Adjusted diluted EPS growth: 12% to 16%

For earnings history and earnings-related data on Stantec (STN) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Is the global equity rally broadening? UBS weighs in
• enVVeno Medical (NVNO) files $100M mixed shelf